Moreover, a large body of evidence shows that different measures of sleep disruption are associated with AD biomarkers (i.e., Aβ, phosphorylated tau, neurodegeneration) in animals [144,145,146] and humans [13,30,130,147,148,149,150,151,152,153,154]. The gene discussed is MAPT; the disease is Alzheimer disease.